Remus Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Remus Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Remus Pharmaceuticals Ltd.
Rating: 1.67166675
Author: Trendlyne DVM scores

about

Remus Pharmaceuticals is engaged in the business of Marketing and distribution of API and Finished Formulations of Pharmaceutical drugs and Provision for Technical consultancy services in various countries including India.

893.30 -35.35 (-3.81%)

36.98% Fall from 52W High

3,500

NSE Volume

NSE 28 Aug, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Not Eligible

Expensive Valuation

21.2 / 100

Technically Neutral

45.7 / 100

No estimates available

Remus Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Remus Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Remus Pharmaceuticals is engaged in the business of Marketing and distribution of API and Finished Formulations of Pharmaceutical drugs and Provision for Technical consultancy services in various countries including India.

36.98% Fall from 52W High

SWOT Analysis

Remus Pharma Live Price Chart